Two-week intensive outpatient trauma program for PTSD
Two-week Intensive Outpatient Trauma Treatment.
This program will test whether a two-week outpatient course combining Prolonged Exposure and EMDR reduces PTSD symptoms and improves functioning in adults with PTSD.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT07565311 on ClinicalTrials.gov |
What this trial studies
Participants with PTSD will receive an outpatient intensive treatment over two weeks combining Prolonged Exposure and EMDR. Up to 42 patients will complete validated self-report measures of PTSD symptoms (PCL-5, ITQ) and quality of life/functioning (WHO-5, WSAS) at baseline, one week, and twelve weeks after treatment. In-depth qualitative interviews with up to 30 participants—focusing on people with minority backgrounds, males, and those with limited benefit—will explore outcomes and needs for adjustment. The study uses a mixed-methods design to combine quantitative symptom change data with qualitative feedback on feasibility and patient experience.
Who should consider this trial
Good fit: Adults aged 18–65 with a diagnosis of PTSD who can give written informed consent and are able to attend the two-week outpatient program.
Not a fit: Patients with active substance abuse, psychotic or bipolar disorders, organic brain disorders, IQ below 70, serious suicide risk, or those currently in life‑threatening situations may not benefit or be eligible.
Why it matters
Potential benefit: If successful, this approach could provide a shorter outpatient option that quickly reduces PTSD symptoms and improves daily functioning.
How similar studies have performed: Previous intensive programs combining EMDR and exposure-based therapies have shown promising symptom reductions, but evidence for combined two-week outpatient formats is still limited and variable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * PTSD * 18-65 years * Able to give written informed consent. Exclusion Criteria: * Active substance abuse * psychotic or bipolar disorder * organic brain disorder * IQ\< 70 * Currently in a life-threating situation. * Serious suicide risk.
Where this trial is running
Oslo
- Oslo University Hospital — Oslo, Norway (Recruiting)
Study contacts
- Principal investigator: Julie H Evensen, MD PhD — Oslo University Hospital
- Study coordinator: Julie H Evensen, MD PhD
- Email: uxevej@ous-hf.no
- Phone: 004799339292
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.